Bildkälla: Stockfoto

Lipigon: Lipisense Tolerated at the Highest Doses - Redeye

Redeye is optimistic about Lipigon’s leading candidate Lipisense after demonstrating a good safety profile at up to 144mg in single ascending doses and 36mg in multiple ascending doses. We raise our Base Case.

Redeye is optimistic about Lipigon’s leading candidate Lipisense after demonstrating a good safety profile at up to 144mg in single ascending doses and 36mg in multiple ascending doses. We raise our Base Case.
Börsvärldens nyhetsbrev
ANNONSER